Latest Trends in Science & Intellectual Property

Resources

A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.

Data quality: The not-so secret sauce for AI and machine learning

The promise of artificial intelligence has always felt more like a future state, but the reality is that many companies are already adopting AI initiatives. This is especially true in the scientific R&D realms. Over the last few years, there has been a huge increase of machine learning and AI initiatives in everything from QSAR models to genomics. According to a 2018 survey, AI adoption grew drastically from 38% in 2017 to 61% in 2018. This occurred across a variety of industries, including healthcare, manufacturing and financial services. However, most early adopters noted one of the biggest challenges to successful implementation involved data, specifically, accessing, protecting, integrating and preparing data for AI initiatives.

Gain a competitive edge with IP Insights from CAS

Find the competitive edge in research and development with IP insights

Learn how incorporating an intellectual property (IP) strategy in research and development plans can give your business a competitive edge.

CAS Future Leaders: On the trail toward scientific leadership

Celebrating its 10th year, the CAS Future Leaders program awards early-career scientists with essential scientific, business and leadership training and a trip to the ACS National Meeting & Exposition. This year, 29 participants from 16 countries took part in programming related to five leadership themes (Storytelling, Insights, Strategies, Perspectives and Impacts), all designed to help them advance their careers and make meaningful impacts in science.

CAS Future Leaders: Forging friendship, collaboration and success

Have you heard about CAS Future Leaders? Since 2010, the program has provided early-career scientists with essential scientific, business and leadership training to help them make meaningful impacts in science. In the weeks to come, we're sharing "where are they now" stories written by our program alumni. This week's post features Fernando Gomollon Bel and Ben Naman, both participants in our 2014 program.

CAS Future Leaders: Driving scientific community engagement across Malaysia

Have you heard about CAS Future Leaders? Since 2010, the program has provided early-career scientists with essential scientific, business and leadership training to help them make meaningful impacts in science. We're sharing "where are they now" stories written by our program alumni. This week's post features two alumni collaborating to elevate the scientific community in Malaysia, Felicia Lim (2018) and Magaret Sivapragasam (2017).

From T to key: The changing shape of today's innovation workforce

While there will always be need for I- and T-shaped professionals, most professionals today can't count on being really good at one thing to succeed. Organizations are increasingly seeking key-shaped candidates when recruiting new talent. So, how can individuals and organizations across industries become more key-shaped?

Press Releases

CAS convenes life sciences advisory board to reimagine the future of scientific discovery

CAS, a division of the American Chemical Society specializing in scientific information solutions, announced today its CAS Life Sciences Advisory Board. The board comprises a world-class panel of global thought leaders, directing the CAS scientific journey to align authoritative content with groundbreaking predictive technologies that span the spectrum of life sciences workflows

Tracking Innovation: Microtrends in Global R&D Growth Reveal Risks and Opportunities

By any measure, global innovation is accelerating at a dizzying pace. R&D spending, global patent applications, venture capital investment volume, and the pace of technology M&A all reflect the increase in activity.

Webinar

Impact of COVID-19: AI and Machine Learning Solutions

As part of the CPhI webinar series, CAS and IQVIA join forces to deliver insights into optimizing Artificial Intelligence and Machine Learning for predictive analytics, clinical trials and drug discovery in response to COVID-19.